Skip to main content

Advertisement

SpringerLink
Log in

Three-year clinical outcome of unprotected left main coronary artery disease patients complicated with chronic kidney disease treated by coronary artery bypass graft versus percutaneous coronary intervention

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

This study aimed to compare the incidence of major adverse cardiac and cerebrovascular events (MACCE) after coronary artery bypass graft (CABG) or after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) in unprotected left main coronary artery disease (ULMCAD) patients complicated with chronic kidney disease (CKD).

Methods

Three hundred sixty-eight ULMCAD patients complicated with CKD who underwent first ever CABG (n = 207) or PCI with DES (n = 161) were recruited in this prospective cohort study. Patients were followed up to MACCE occurrence or 36 months after operations, and accumulating MACCE occurrence was calculated.

Results

Accumulating MACCE occurrence was decreased in CABG group compared with PCI group (P = 0.007). Subgroup analysis showed that CKD stage positively correlated with accumulating MACCE occurrence in total patients (P = 0.006) and in PCI-treated patients (P = 0.018), but not in CABG-treated patients (P = 0.217). Further univariate Cox’s regression model displayed that CABG (versus (vs.) PCI) (P = 0.008) was associated with lower accumulating MACCE occurrence, while age (≥ 65 years) (P = 0.048), hyperlipidemia (P = 0.013), diabetes (P = 0.012), previous heart failure (P = 0.011), previous stroke (P = 0.030), LVEF < 50% (P = 0.048), higher CKD stage (P = 0.002), and more diseased vessels (P = 0.022) were associated with increased accumulating MACCE occurrence. Forward stepwise multivariate Cox’s regression model disclosed that CABG (vs. PCI) (P = 0.002) independently predicted decreased accumulating MACCE occurrence, whereas hyperlipidemia (P = 0.033), diabetes (P = 0.002), higher CKD stage (P = 0.001), and more diseased vessels (P = 0.009) independently predicted elevated accumulating MACCE occurrence.

Conclusion

CABG could be considered as the preferred treatment strategy compared with PCI with DES in ULMCAD patients complicated with CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. De Rosa S, Polimeni A, Sabatino J, Indolfi C (2017) Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis. BMC Cardiovasc Disord 17(1):240

    Article  Google Scholar 

  2. Nagarajarao HS, Ojha CP, Mulukutla V et al (2020) Current use and trends in unprotected left main coronary artery percutaneous intervention. Curr Cardiol Rep 22(4):16

    Article  Google Scholar 

  3. Levine GN, Bates ER, Blankenship JC et al (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 124(23):e574–e651

    PubMed  Google Scholar 

  4. O’Gara PT (2018) PCI or CABG for LMCA revascularization in patients with CKD: the jury is still out. J Am Coll Cardiol 72(7):766–768

    Article  Google Scholar 

  5. Bachar BJ, Manna B (2020) Coronary artery bypass graft. In: StatPearls. Treasure Island (FL)

  6. Lin TC, Lu TM, Huang FC et al (2018) Coronary artery bypass surgery versus percutaneous coronary intervention for left main coronary artery disease with chronic kidney disease. Int Heart J 59(2):279–285

    Article  Google Scholar 

  7. Karkhanis R, Tam DY, Fremes SE (2018) Management of patients with end-stage renal disease: coronary artery bypass graft surgery versus percutaneous coronary intervention. Curr Opin Cardiol 33(5):546–550

    Article  Google Scholar 

  8. Taggart DP (2013) CABG or stents in coronary artery disease: end of the debate? Lancet 381(9867):605–607

    Article  Google Scholar 

  9. Kim DW, Om SY, Park MW et al (2019) Comparative effectiveness analysis of percutaneous coronary intervention vs. coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery disease: insights from a large-sized all-comers registry. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

  10. Bhatt DL (2018) Percutaneous Coronary Intervention in 2018. Jama 319(20):2127–2128

    Article  Google Scholar 

  11. Kilic A, Sultan I, Gleason TG et al (2019) Surgical versus percutaneous multivessel coronary revascularization in patients with chronic kidney disease. Eur J Cardiothorac Surg

  12. Deb S, Wijeysundera HC, Ko DT et al (2013) Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. Jama 310(19):2086–2095

    Article  CAS  Google Scholar 

  13. Levey AS, de Jong PE, Coresh J et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 80(1):17–28

    Article  Google Scholar 

  14. Hillis LD, Smith PK, Anderson JL et al (2011) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124(23):e652–e735

    PubMed  Google Scholar 

  15. Levine GN, Bates ER, Blankenship JC et al (2013) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 82(4):E266–E355

    PubMed  Google Scholar 

  16. Kang SH, Ahn JM, Lee CH et al (2017) Differential event rates and independent predictors of long-term major cardiovascular events and death in 5795 patients with unprotected left main coronary artery disease treated with stents, bypass surgery, or medication: insights from a large international multicenter registry. Circ Cardiovasc Interv 10(7)

  17. Johnson RC, Leopold JA, Loscalzo J (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99(10):1044–1059

    Article  CAS  Google Scholar 

  18. Lazaros G, Toutouzas K, Drakopoulou M et al (2013) Aortic sclerosis and mitral annulus calcification: a window to vascular atherosclerosis? Expert Rev Cardiovasc Ther 11(7):863–877

    Article  CAS  Google Scholar 

  19. Lamelas P, Belardi J, Whitlock R, Stone GW (2019) Limitations of repeat revascularization as an outcome measure: JACC review topic of the week. J Am Coll Cardiol 74(25):3164–3173

    Article  Google Scholar 

  20. Parasca CA, Head SJ, Milojevic M et al (2016) Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: the SYNTAX trial at 5 years. JACC Cardiovasc Interv 9(24):2493–2507

    Article  Google Scholar 

  21. Cai Q, Mukku VK, Ahmad M (2013) Coronary artery disease in patients with chronic kidney disease: a clinical update. Curr Cardiol Rev 9(4):331–339

    Article  Google Scholar 

  22. Wiernek SL, Kiesz RS, Wiernek BK et al (2015) Treatment of symptomatic coronary artery disease in patients with end-stage renal disease on hemodialysis with paclitaxel-eluting TAXUS stent. Hemodial Int 19(3):402–411

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Shijiazhuang, 050000, China

    Xun Wang, Jiayu Zhao, Haiyan Wang, Ying Zhao & Xianghua Fu

Authors
  1. Xun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiayu Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haiyan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ying Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xianghua Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xianghua Fu.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Ethics statement

This study was approved by the Institutional Review Board of our hospital, and all patients provided the written informed consents.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Zhao, J., Wang, H. et al. Three-year clinical outcome of unprotected left main coronary artery disease patients complicated with chronic kidney disease treated by coronary artery bypass graft versus percutaneous coronary intervention. Ir J Med Sci 190, 89–96 (2021). https://doi.org/10.1007/s11845-020-02257-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-020-02257-9

Keywords

Search

Navigation